&lt;p&gt;An Overview of the Treatment of Symptomatic Common Femoral Artery Lesions with a Focus on Endovascular Therapy&lt;/p&gt;

Shammas, Nicolas W.; Doumet, Amanda Abi; Karia, Rusina; Khalafallah, Rommy

doi:10.2147/vhrm.s242291

Cited by 9 publications

(3 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The incidence of hypertension and diabetes was 59.4% and 55.5%, respectively. Most of the patients (63.3%) presented with moderate claudication (Rutherford Class 3),[ 2 ] and proximal superficial femoral artery (SFA) was the most common lesion site in 82.5% of the patients. Baseline demographic and clinical characteristics of the patients are shown in Table 1 and lesion features are presented in Table 2.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Endovascular balloon angioplasty for infrainguinal arterial occlusive disease: Efficacy analysis

Sarıcaoğlu¹

2021

Turk Gogus Kalp Dama

View full text Add to dashboard Cite

Background We present early and mid-term clinical outcomes of endovascular revascularization for femoropopliteal involvement of peripheral arterial disease. Methods A total of 128 patients (113 males, 15 females; mean age: 63.4±9.9 years; range, 32 to 87 years) who underwent percutaneous transluminal angioplasty for femoropopliteal lesions between August 2016 and April 2018 were analyzed retrospectively. Treatment with Luminor® paclitaxel-coated drug-eluting balloon catheter or bailout therapy with iVolution® self-expanding nitinol stent were performed. Overall patency rates and freedom from reintervention rates were analyzed using the Kaplan-Meier analysis. The primary patency and freedom from reintervention to target lesion rates at 12 and 24 months were evaluated. Results Technical success was achieved in 133 (93%) of the interventions with a median follow-up of 11 (range, 1 to 35) months. At 12 and 24 months, the mean overall patency rates were 85.6±3.7% and 66.8±6.7%, respectively and the mean freedom from reintervention to target lesion rates were 91.6±2.9% and 78.1±6.3%, respectively. The primary patency and freedom from reintervention to target lesion rates were significantly higher in the bailout stenting group than the drug-eluting balloon group at 12 months (97.3±2.7% vs. 94.8±6.1%, respectively, p=0.025 and 97.1±2.9% vs. 84.2±5.5%, respectively, p=0.005) and at 24 months (76.9±7.9% vs. 55.8±13.4%, respectively, p=0.025 and 85.2±7.0% vs. 70.2±13.6%, respectively, p=0.005). Conclusion Endovascular procedures including drug-eluting balloon and bailout stenting seem to be effective alternative treatment modalities for treatment of infrainguinal peripheral arterial disease and can be also used in patients with long lesions and/or total occlusion of femoropopliteal arteries.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Endovascular strategies have become a well-recognized therapeutic alternative to bypass surgery with the aforementioned technical advancements. [ 2 ]…”

Section: Introductionmentioning

confidence: 99%

Endovascular balloon angioplasty for infrainguinal arterial occlusive disease: Efficacy analysis

Sarıcaoğlu¹

2021

Turk Gogus Kalp Dama

View full text Add to dashboard Cite

show abstract

“…7,20 Atherectomy is useful in mechanically debulking heavily calcified atherosclerotic plaques from the vessel's intimal layer and is usually combined with balloon angioplasty with the goal of minimizing plaque shift and avoiding stent placement. 21 However, in a study by Rocha-Singh et al, 22 atherectomy was associated with removal of more than 1 vessel wall layers, with tunica adventitia seen in about 39% of histological samples. While the role of DCB for the treatment of symptomatic peripheral arterial disease is well established, when used alone in heavily calcified disease, it has poor technical success and patency.…”

Section: Discussionmentioning

confidence: 97%